| (84) |
Designated Contracting States: |
|
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
| (30) |
Priority: |
27.03.2001 US 279085 P 31.10.2001 US 334854 P
|
| (43) |
Date of publication of application: |
|
02.10.2002 Bulletin 2002/40 |
| (73) |
Proprietors: |
|
- Novartis AG
4056 Basel (CH)
- Novartis Pharma GmbH
1230 Wien (AT) Designated Contracting States: AT
|
|
| (72) |
Inventor: |
|
- Russel, Todd Aldridge
Grayson,
GA 30017 (US)
|
| (74) |
Representative: Molac, Béatrice et al |
|
Novartis AG
Corporate Intellectual Property
Patent and Trademark Department 4002 Basel 4002 Basel (CH) |
| (56) |
References cited: :
EP-A- 0 825 013 US-A- 4 565 348
|
WO-A-00/18567 US-A- 5 466 147
|
|
| |
|
|
|
|